Medicane Portugal | Products

Our Products

In our GACP-certified hybrid greenhouse, MediCane cultivates craft cannabis from a selection of strains based on science and research. All plants and cultivation processes are rigorously inspected by our pharmaceutical Quality Assurance team to ensure flowers are in full compliance with EU-GMP standards.  

The strains offered have diverse chemical profiles that accommodate to the needs of all your patients. And whilst our catalogue does meet the current demand for ‘popular’ strains, we also bring to market new strains with a high potential for therapeutic benefits.

High THC

THC, known for its psychoactive properties, provides a potent relief for chronic pain, insomnia, and nausea.

Balanced THC:CBD

Not wanting to lose the benefits of THC and wanting to capture the myriad of medical benefits that CBD has to offer, including anxiety relief, anti-inflammatory effects, and seizure management, we cultivate strains that offer a balance between THC content and CBD content.

Seed-to-Customer

seed to customer

MediCane seed-to-costumer business model allows comprehensive monitoring and control of the cultivation process, along with subsequent medical and pharmaceutical R&D. This model includes genetic seed development, plant propagation, and cultivation, manufacturing, pharmacological development, medical research, and distribution of the final products to end-users. 

Our genetic bank contains verity of strains that are organically cultivated in our state-of-the-art greenhouses and then processed in post-harvest and manufacturing facilities under ISO 9001, GAP and GMP quality standards. The distribution of the final products to end-users is carried out through a global BTB and BTC partner network.

By carefully controlling the value chain of medicinal cannabis MediCane aims to deliver APIs of the highest pharma-grade quality. Our genetic bank contains over 100 strains that are organically cultivated in our state-of-the-art greenhouses and then processed in post-harvest and manufacturing facilities under ISO 9001, GAP and GMP quality standards. The distribution of the final products to end-users is carried out through a global BTB and BTC partner network.

MCFC Medical Chemical-Free Cannabis

MCFC (Medical Chemical-Free Cannabis) is a joint venture of MediCane and Yissum, a technology transfer company of the Hebrew University of Jerusalem

MCFC was established with the aim to eliminate the use of chemical insecticides by employing patented RF technology. It is a cost-effective, non-toxic and versatile solution that replaces the use of dangerous pesticides, making organic cannabis products safer. 

MediCane holds the exclusive right to distribute the Canna-Wave device, a patented hardware and software electronic system based on proven Radio Frequency (RF) which ensures the cannabis greenhouses is 100% insecticide and insect free. With Canna-Wave we quickly, safely and cost effectively hinder insect infestations in our greenhouses without the use of dangerous insecticides. 

turkiz_sq
wave
Skip to content